CIK 0001595097 · Non-accelerated filer<br>Smaller reporting company
Corbus Pharmaceuticals Holdings, Inc.
Sign in to watch- Ticker
- CRBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464348039
- Phone
- 617-963-0103
- Business address
- 500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
- Former names
- SAV Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,758,438
- in 2 filings, $16K under 10b5-1 plans
Net −$1,758,438. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-17 | Cohen Yuval Chief Executive Officer | Option exercise 10b5-1 | +9,333 | $30.00 | $280K | 93,733 |
| 2024-06-17 | Cohen Yuval Chief Executive Officer | Sale 10b5-1 | −9,333 | $46.02 | $430K | 84,400 |
| 2024-06-17 | Cohen Yuval Chief Executive Officer | Option exercise 10b5-1 | +1,770 | $4.26 | $8K | 86,170 |
| 2024-06-17 | Cohen Yuval Chief Executive Officer | Sale 10b5-1 | −1,770 | $46.02 | $81K | 84,400 |
| 2024-06-17 | Cohen Yuval Chief Executive Officer | Option exercise · Options to purchase common stock 10b5-1 | −9,333 | 11,667 | ||
| 2024-06-17 | Cohen Yuval Chief Executive Officer | Option exercise · Options to purchase common stock 10b5-1 | −1,770 | 52,061 | ||
| 2024-06-14 | Moran Sean F. Chief Financial Officer | Option exercise 10b5-1 | +1,567 | $30.00 | $47K | 50,172 |
| 2024-06-14 | Moran Sean F. Chief Financial Officer | Sale 10b5-1 | −1,567 | $49.87 | $78K | 48,605 |
| 2024-06-14 | Moran Sean F. Chief Financial Officer | Option exercise 10b5-1 | +7,788 | $4.26 | $33K | 56,393 |
| 2024-06-14 | Moran Sean F. Chief Financial Officer | Sale 10b5-1 | −7,788 | $49.87 | $388K | 48,605 |
| 2024-06-14 | Moran Sean F. Chief Financial Officer | Option exercise · Options to purchase common stock 10b5-1 | −1,567 | 1,958 | ||
| 2024-06-14 | Moran Sean F. Chief Financial Officer | Option exercise · Options to purchase common stock 10b5-1 | −7,788 | 23,367 | ||
| 2024-06-14 | Cohen Yuval Chief Executive Officer | Option exercise 10b5-1 | +16,830 | $14.10 | $237K | 101,230 |
| 2024-06-14 | Cohen Yuval Chief Executive Officer | Sale 10b5-1 | −16,830 | $50.17 | $844K | 84,400 |
| 2024-06-14 | Cohen Yuval Chief Executive Officer | Option exercise 10b5-1 | +12,487 | $4.26 | $53K | 96,887 |
| 2024-06-14 | Cohen Yuval Chief Executive Officer | Sale 10b5-1 | −12,487 | $50.17 | $626K | 84,400 |
| 2024-06-14 | Cohen Yuval Chief Executive Officer | Option exercise · Options to purchase common stock 10b5-1 | −16,830 | 32,827 | ||
| 2024-06-14 | Cohen Yuval Chief Executive Officer | Option exercise · Options to purchase common stock 10b5-1 | −12,487 | 53,831 | ||
| 2024-06-14 | HOLMER ALAN F Director | Option exercise | +1,667 | $30.00 | $50K | 5,829 |
| 2024-06-14 | HOLMER ALAN F Director | Option exercise · Options to purchase common stock | −1,667 | 0 |
Page 6 of 10 · 200 trades